Hedberg, M. L., Peyser, N. D., Bauman, J. E., Gooding, W. E., Li, H., Bhola, N. E., . . . Grandis, J. R. (2019). Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for PIK3CA -altered head and neck cancer. The Journal of experimental medicine, 216(2), 419-427. https://doi.org/10.1084/jem.20181936
Chicago Style (17th ed.) CitationHedberg, Matthew L., et al. "Use of Nonsteroidal Anti-inflammatory Drugs Predicts Improved Patient Survival for PIK3CA -altered Head and Neck Cancer." The Journal of Experimental Medicine 216, no. 2 (2019): 419-427. https://doi.org/10.1084/jem.20181936.
MLA (9th ed.) CitationHedberg, Matthew L., et al. "Use of Nonsteroidal Anti-inflammatory Drugs Predicts Improved Patient Survival for PIK3CA -altered Head and Neck Cancer." The Journal of Experimental Medicine, vol. 216, no. 2, 2019, pp. 419-427, https://doi.org/10.1084/jem.20181936.